Titre:
  • Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel?
Auteur:Van Praet, Charles; Filleul, Bertrand; Schallier, Denis; Machiels, Jean Pascal; Schrijvers, Dirk; Everaert, Els; D'Hondt, Lionel; Werbrouck, Patrick; Vermeij, Joanna; Mebis, Jeroen; Clausse, Marylene; Rottey, Sylvie; Rasschaert, Marika; Van Erps, Joanna; Verheezen, Jolanda; Van Haverbeke, Jan; Goeminne, Jean Charles; Lumen, Nicolaas; Van Hende, Fransien; Pelgrims, Gino; Demey, Wim; Van Aelst, Filip; Wynendaele, Wim; Gil, Thierry; Schatteman, Peter
Informations sur la publication:Clinical Genitourinary Cancer, 15, 4, page (502-508)
Statut de publication:Publié, 2017-08
Sujet CREF:Cancérologie
Néphrologie - urologie
Mots-clés:Chemotherapy
Prognosis
Prostatic neoplasms
Steroids
Survival
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1558-7673
info:doi/10.1016/j.clgc.2017.01.019
info:pii/S1558767317300356
info:scp/85014057026